Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Achilles Therapeutics PLC ADR stock
Learn how to easily invest in Achilles Therapeutics PLC ADR stock.
Achilles Therapeutics PLC ADR is a biotechnology business based in the US. Achilles Therapeutics PLC ADR shares (ACHL) are listed on the NASDAQ and all prices are listed in US Dollars. Achilles Therapeutics PLC ADR employs 234 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Achilles Therapeutics PLC ADR stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACHL. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Commission-free stock and ETF trades
- No management fees
- Customizable portfolios with automatic rebalancing
Achilles Therapeutics PLC ADR stock price (NASDAQ: ACHL)Use our graph to track the performance of ACHL stocks over time.
Achilles Therapeutics PLC ADR shares at a glance
|Latest market close||$1.02|
|52-week range||$0.75 - $3.45|
|50-day moving average||$0.93|
|200-day moving average||$1.54|
|Wall St. target price||$8.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.84|
Buy Achilles Therapeutics PLC ADR stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Achilles Therapeutics PLC ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Achilles Therapeutics PLC ADR price performance over time
Historical closes compared with the close of $1.0174 from 2023-06-02
|1 week (2023-05-26)||0.63%|
|1 month (2023-05-05)||14.64%|
|3 months (2023-03-03)||-4.93%|
|6 months (2022-12-05)||-40.50%|
|1 year (2022-06-03)||-58.98%|
|2 years (2021-06-04)||-91.93%|
|3 years (2020-06-01)||N/A|
|5 years (2018-06-01)||N/A|
Achilles Therapeutics PLC ADR financials
|Gross profit TTM||$0|
|Return on assets TTM||-17.7%|
|Return on equity TTM||-31.59%|
|Market capitalisation||$41.8 million|
TTM: trailing 12 months
Achilles Therapeutics PLC ADR share dividends
We're not expecting Achilles Therapeutics PLC ADR to pay a dividend over the next 12 months.
Achilles Therapeutics PLC ADR share price volatility
Over the last 12 months, Achilles Therapeutics PLC ADR's shares have ranged in value from as little as $0.75 up to $3.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achilles Therapeutics PLC ADR's is 0.9307. This would suggest that Achilles Therapeutics PLC ADR's shares are less volatile than average (for this exchange).
To put Achilles Therapeutics PLC ADR's beta into context you can compare it against those of similar companies.
- Catalyst Pharmaceuticals (CPRX.US): 1.1091
- BioDelivery Sciences International (BDSI.US): 0.5551
- Trillium Therapeutics (TRIL.US): 1.9046
Achilles Therapeutics PLC ADR overview
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom. .
Achilles Therapeutics PLC ADR in the news
3 Stocks With 1,000% Upside Potential
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
Frequently asked questionsWhat percentage of Achilles Therapeutics PLC ADR is owned by insiders or institutions?
Currently 5.963% of Achilles Therapeutics PLC ADR shares are held by insiders and 61.383% by institutions. How many people work for Achilles Therapeutics PLC ADR?
Latest data suggests 234 work at Achilles Therapeutics PLC ADR. When does the fiscal year end for Achilles Therapeutics PLC ADR?
Achilles Therapeutics PLC ADR's fiscal year ends in December. Where is Achilles Therapeutics PLC ADR based?
Achilles Therapeutics PLC ADR's address is: 245 Hammersmith Road, London, United Kingdom, W6 8PW What is Achilles Therapeutics PLC ADR's ISIN number?
Achilles Therapeutics PLC ADR's international securities identification number is: US00449L1026
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert